APA (7th ed.) Citation

Burbury, K., Gambell, P., Neeson, P., Chen, K., Kenealy, M., Seymour, J., . . . Ritchie, D. (2011). 195 Biomarkers for response to lenalidomide (LEN) treatment in patients with myelodysplastic syndromes (MDS). Leukemia Research, 35, S77. https://doi.org/10.1016/S0145-2126(11)70197-7

Chicago Style (17th ed.) Citation

Burbury, K., P. Gambell, P. Neeson, K. Chen, M. Kenealy, J.F Seymour, H.M Prince, D. Westerman, and D. Ritchie. "195 Biomarkers for Response to Lenalidomide (LEN) Treatment in Patients with Myelodysplastic Syndromes (MDS)." Leukemia Research 35 (2011): S77. https://doi.org/10.1016/S0145-2126(11)70197-7.

MLA (9th ed.) Citation

Burbury, K., et al. "195 Biomarkers for Response to Lenalidomide (LEN) Treatment in Patients with Myelodysplastic Syndromes (MDS)." Leukemia Research, vol. 35, 2011, p. S77, https://doi.org/10.1016/S0145-2126(11)70197-7.